Vitronectin increases vascular permeability by promoting VE-cadherin internalization at cell junctions

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Li, Rong ^a   Ren, Meiping ^a   Chen, Ni ^a   Luo, Mao ^a   Zhang, Zhuo ^a   Wu, Jianbo ^a,b  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 2 OXO 3 (4,5,6,7 TETRAHYDRO 1H INDOL 2 YLMETHYLENE) 1H INDOLE 5 SULFONIC ACID DIMETHYLAMIDE; BETA3 INTEGRIN; CD51 ANTIGEN; DEXTRAN; ETARACIZUMAB; FLUORESCEIN ISOTHIOCYANATE; PROTEIN TYROSINE KINASE; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VITRONECTIN; CADHERIN; LEUKOCYTE ANTIGEN; RECOMBINANT PROTEIN; SMALL INTERFERING RNA; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL CONTACT; CELL INFILTRATION; CELL JUNCTION; CONTROLLED STUDY; FEMALE; GENE SILENCING; HINDLIMB; HUMAN; HUMAN CELL; INTERNALIZATION; LEG ISCHEMIA; MACROPHAGE; MALE; MOUSE; MUSCLE BLOOD FLOW; NONHUMAN; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN MULTIMERIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; C57BL MOUSE; CAPILLARY PERMEABILITY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; ISCHEMIA; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

MUS;

ANIMALS; ANTIGENS, CD; CADHERINS; CAPILLARY PERMEABILITY; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR JUNCTIONS; ISCHEMIA; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN MULTIMERIZATION; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; SRC-FAMILY KINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITRONECTIN;

EID: 84861013031     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037195     Document Type: Article

References (39)

1. van Aken BE, Seiffert D, Thinnes T, Loskutoff DJ, (1997) Localization of vitronectin in the normal and atherosclerotic human vessel wall. Histochem Cell Biol. 107: 313-320.
2. Dufourcq P, Louis H, Moreau C, Daret D, Boisseau MR, et al. (1998) Vitronectin expression and interaction with receptors in smooth muscle cells from human atheromatous plaque. Arterioscler Thromb Vasc Biol 18: 168-176.
3. Davis GE, Bayless KJ, Davis MJ, Meininger GA, (2000) Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules. Am J Pathol 156: 1489-1498.
4. Jang YC, Tsou R, Gibran NS, Isik FF, (2000) Vitronectin deficiency is associated with increased wound fibrinolysis and decreased microvascular angiogenesis in mice. Surgery 127: 696-704.
5. Davis GE, (2010) Matricryptic sites control tissue injury responses in the cardiovascular system: relationships to pattern recognition receptor regulated events. J Mol Cell Cardiol 48: 454-460.
6. Qiao RL, Yan W, Lum H, Malik AB, (1995) Arg-Gly-Asp peptide increases endothelial hydraulic conductivity: comparison with thrombin response. Am J Physiol 269: C110-117.
7. Alghisi GC, Ponsonnet L, Rüegg C, (2009) The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells. PLoS One. 4: e4449.
8. Liu Y, Senger DR, (2004) Matrix-specific activation of Src and Rho initiates capillary morphogenesis of endothelial cells. FASEB J. 18: 457-468.
9. Wang Y, Jin G, Miao H, Li JY, Usami S, et al. (2006) Integrins regulate VE-cadherin and catenins: dependence of this regulation on Src, but not on Ras. Proc Natl Acad Sci U S A 103: 1774-1779.
10. Soldi R, Mitola S, Strasly M, Defilippi P, Tarone G, et al. (1999) Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J. 18: 882-892.
11. Brakenhielm E, (2007) Substrate matters: reciprocally stimulatory integrin and VEGF signaling in endothelial cells. Circ Res 101: 536-538.
12. Mahabeleshwar GH, Feng W, Reddy K, Plow EF, Byzova TV, (2007) Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis. Circ Res 101: 570-580.
13. Kanse SM, Matz RL, Preissner KT, Peter K, (2004) Promotion of leukocyte adhesion by a novel interaction between vitronectin and the beta2 integrin Mac-1 (alphaMbeta2, CD11b/CD18). Arterioscler Thromb Vasc Biol 24: 2251-2256.
14. Tsuruta Y, Park YJ, Siegal GP, Liu G, Abraham E, (2007) Involvement of vitronectin in lipopolysaccaride-induced acute lung injury. J Immunol 179: 7079-7086.
15. Gavard J, Gutkind JS, (2006) VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 8: 1223-1234.
16. Dejana E, Corada M, Lampugnani MG, (1995) Endothelial cell-to-cell junctions. FASEB J 9: 910-918.
17. Navaratna D, McGuire PG, Menicucci G, Das A, (2007) Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes. Diabetes 56: 2380-2387.
18. Xiao K, Allison DF, Buckley KM, Kottke MD, Vincent PA, et al. (2003) Cellular levels of p120 catenin function as a set point for cadherin expression levels in microvascular endothelial cells. J Cell Biol 163: 535-545.
19. Weis S, Shintani S, Weber A, Kirchmair R, Wood M, et al. (2004) Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J Clin Invest 113: 885-894.
20. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, et al. (2000) Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6: 460-463.
21. Tomasini BR, Mosher DF, (1998) Conformational states of vitronectin: preferential expression of an antigenic epitope when vitronectin is covalently and noncovalently complexed with thrombin-antithrombin III or treated with urea. Blood 72: 903-912.
22. Seiffert D, Loskutoff DJ, (1996) Type 1 plasminogen activator inhibitor induces multimerization of plasma vitronectin. A suggested mechanism for the generation of the tissue form of vitronectin in vivo. J Biol Chem 271: 29644-29651.
23. Kanse SM, Kost C, Wilhelm OG, Andreasen PA, Preissner KT, (1996) The urokinase receptor is a major vitronectin-binding protein on endothelial cells. Exp Cell Res 224: 344-353.
24. Zanetti A, Conforti G, Hess S, Martìn-Padura I, Ghibaudi E, et al. (1994) Clustering of vitronectin and RGD peptides on microspheres leads to engagement of integrins on the luminal aspect of endothelial cell membrane. Blood 84: 1116-1123.
25. Yamaoka-Tojo M, Tojo T, Kim HW, Hilenski L, Patrushev NA, et al. (2006) IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis. Arterioscler Thromb Vasc Biol 26: 1991-1997.
26. Wu MH, Ustinova E, Granger HJ, (2001) Integrin binding to fibronectin and vitronectin maintains the barrier function of isolated porcine coronary venules. J Physiol. 532: 785-791.
27. Ma C, Rong Y, Radiloff DR, Datto MB, Centeno B, et al. (2008) Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes Dev. 22: 308-321.
28. Lambeng N, Wallez Y, Rampon C, Cand F, Christé G, et al. (2005) Vascular endothelial-cadherin tyrosine phosphorylation in angiogenic and quiescent adult tissues. Circ Res 96: 384-391.
29. Alghisi GC, Rüegg C, (2006) Vascular integrins in tumor angiogenesis: mediators and therapeutic targets. Endothelium 13: 113-135.
30. Gotsch U, Borges E, Bosse R, Böggemeyer E, Simon M, et al. (1997) VE-cadherin antibody accelerates neutrophil recruitment in vivo. J Cell Sci 110: 583-588.
31. Corada M, Mariotti M, Thurston G, Smith K, Kunkel R, et al. (1999) Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci U S A 96: 9815-9820.
32. Corada M, Liao F, Lindgren M, Lampugnani MG, Breviario F, et al. (2001) Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability. Blood 97: 1679-1684.
33. Sen U, Moshal KS, Tyagi N, Kartha GK, Tyagi SC, (2006) Homocysteine-induced myofibroblast differentiation in mouse aortic endothelial cells. J Cell Physiol 209: 767-774.
34. Ackah E, Yu J, Zoellner S, Iwakiri Y, Skurk C, et al. (2005) Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis. J Clin Invest. 115: 2119-2127.
35. Zheng X, Saunders TL, Camper SA, Samuelson LC, Ginsburg D, (1995) Vitronectin is not essential for normal mammalian development and fertility. Proc Natl Acad Sci U S A 92: 12426-12430.
36. Kim HW, Lin A, Guldberg RE, Ushio-Fukai M, Fukai T, (2007) Essential role of extracellular SOD in reparative neovascularization induced by hindlimb ischemia. Circ Res 101: 409-419.
37. Sano K, Asanuma-Date K, Arisaka F, Hattori S, Ogawa H, (2007) Changes in glycosylation of vitronectin modulate multimerization and collagen binding during liver regeneration. Glycobiology 17: 784-794.
38. Laemmli UK, (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
39. Seiffert D, Keeton M, Eguchi Y, Sawdey M, Loskutoff DJ, (1991) Detection of vitronectin mRNA in tissues and cells of the mouse. Proc Natl Acad Sci U S A 88: 9402-9406.